MedCity News -- A better way to fund medical devices? Call it “early in early out.” Mach Ventures’ approach to investing in medical devices: sell after the company proves the device can work or after FDA approval. “No infrastructure, no management, and no duplication that the acquirer needs to get rid of. It’s more honest’and a lot more fun,” writes John Lonergan, Mach’s managing member. Lonergan says the current venture capital approach fails medical devices (and biotech, for that matter).
